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Background: Escherichia coli pyridoxine 5′-phosphate oxidase (PNPOx)
catalyzes the terminal step in the biosynthesis of pyridoxal 5′-phosphate (PLP),
a cofactor used by many enzymes involved in amino acid metabolism. The
enzyme oxidizes either the 4′-hydroxyl group of pyridoxine 5′-phosphate (PNP)
or the 4′-primary amine of pyridoxamine 5′-phosphate (PMP) to an aldehyde.
PNPOx is a homodimeric enzyme with one flavin mononucleotide (FMN)
molecule non-covalently bound to each subunit. A high degree of sequence
homology among the 15 known members of the PNPOx family suggests that all
members of this group have similar three-dimensional folds.
Results: The crystal structure of PNPOx from E. coli has been determined to
1.8 Å resolution. The monomeric subunit folds into an eight-stranded β sheet
surrounded by five α-helical structures. Two monomers related by a twofold axis
interact extensively along one-half of each monomer to form the dimer. There
are two clefts at the dimer interface that are symmetry-related and extend from
the top to the bottom of the dimer. An FMN cofactor that makes interactions
with both subunits is located in each of these two clefts. 
Conclusions: The structure is quite similar to the recently deposited 2.7 Å
structure of Saccharomyces cerevisiae PNPOx and also, remarkably, shares a
common structural fold with the FMN-binding protein from Desulfovibrio
vulgaris and a domain of chymotrypsin. This high-resolution E. coli PNPOx
structure permits predictions to be made about residues involved in substrate
binding and catalysis. These predictions provide testable hypotheses, which
can be answered by making site-directed mutants.
Introduction 
Pyridoxal 5′-phosphate (PLP) is a cofactor that is required
by more than 50 cellular enzymes, the majority of which are
involved in amino acid metabolism. PNPOx catalyzes the
terminal step in the de novo synthesis of PLP in
Escherichia coli as shown in Figure 1; it also serves as a critical
constituent in the recycling of PLP in higher organisms that
require vitamin B6 [1]. In addition to catalyzing the pyridox-
ine 5′-phosphate (PNP) reaction, the enzyme can also
employ pyridoxamine 5′-phosphate (PMP) as a substrate. 
PNPOx has been purified and characterized from rabbit
liver, pig, sheep and rat brain, and E. coli [2–6]. The most
extensive studies have been performed with the rabbit
liver enzyme [7–11]. Each of the purified enzymes is a
homodimer. These previous studies suggested that a
single flavin mononucleotide (FMN) molecule is nonco-
valently bound to the dimer, but more extensive work
with the E. coli enzyme suggests that there are two mol-
ecules of FMN per dimer [6]. Across the 15 available
sequences for PNPOx, molecular weights of the monomer
vary from 22 to 29 kDa with many of the core residues
conserved. Among the 15 members of the PNPOx family,
26 residues (12%) are found to be identical and 129 (59%)
are identical or highly conserved. Excluding the N termi-
nal residues, where the largest sequence variations are
found, the high degree of sequence homology suggests
that all members of the PNPOx family have the same
fold. The PNPOx enzymes are the smallest members of
the flavin-containing oxidase class.
Key questions regarding this enzyme are the mechanisms
of the electron transfer from PNP to FMN and the regu-
lation of its activity. The product PLP has a greater affin-
ity for the active site than either of the substrates PNP or
PMP, suggesting that product inhibition is one mode of
regulation [1,2]. Electron transfer has been proposed to
occur either by direct hydride transfer from C4′ of PNP
to N5 of FMN or removal of a proton by a basic amino
acid to form a C4′ carbanion, which attacks N5 of FMN
[12,13]. Extensive characterization of both substrate and
coenzyme specificity has been performed. In addition to
PNP and PMP, the enzyme can use a number of substi-
tuted secondary amines of PMP as substrates, suggesting
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that the C4′ hydroxyl of PNP or amine of PMP are
solvent exposed [7,14]. The FMN cofactor shows rather
strict structural requirements with only a few alterations
in the isoalloxazine ring being permitted [8].
In this paper we report the structure of E. coli PNPOx
determined to 1.8 Å resolution. The structure reveals a
twofold related dimeric structure with each monomer con-
taining a two-domain α/β-barrel fold with two FMN mol-
ecules bound at the dimer interface. The structure permits
an interpretation of much of the work previously published
on the rabbit liver enzyme. This includes key residues
involved in both FMN and substrate binding, and several
residues that are important to catalysis [9,10,14]. These key
residues are conserved in the currently available sequences
for PNPOx. Using site-directed mutants of E. coli PNPOx
will permit the testing of the role of several of the proposed
key residues in substrate binding and catalysis.
Results
Structure determination and quality of the model
The protein structure of the selenomethionyl (SeMet)
derivative of E. coli PNPOx complexed with FMN was
determined using multiwavelength anomalous diffraction
(MAD). There are five methionine residues in the
protein sequence, but only four of them (residues 53, 79,
113 and 127) are observed in the SeMet protein structure.
These four were used to obtain the initial phases. With
the exception of SeMet127, which is exposed to the
solvent, the rest are buried deeply inside the protein. The
fifth SeMet, at the N terminus, has been cleaved in vivo
as confirmed by amino acid sequencing, and is not
present in the purified protein. 
The final crystallographic R factor and Rfree [15] are 21.0%
and 23.3%, respectively, for all data in the resolution range
55.0–1.8 Å. The crystal belongs to the space group P3121
and has one monomer in the asymmetric unit. The final
model for the monomer contained 199 amino acid residues,
one tightly bound FMN molecule, one phosphate mol-
ecule, and 128 water molecules. Two regions comprising
residues 131–137 and 164–174 have high B-factors (51.0 Å2
and 52.1 Å2, respectively) compared with the average for
the protein (25.4 Å2). The average coordinate error is
0.16 Å as estimated using SIGMAA [16]. Of the total
number of residues, 89.8% are found in the most favored
regions of the Ramachandran plot as calculated using
PROCHECK [17]. Most of the residues that are located in
areas of high B-factors and poorly defined densities are
found in the additional allowed regions. There are no
residues in the disallowed regions of the Ramachandran
plot. Other statistical values are listed in Tables 1 and 2. 
Monomeric structure description
The crystallographic asymmetric unit contains one
monomer (A) of the E. coli PNPOx. The second monomer
(B) in the E. coli PNPOx dimeric structure is generated by
the crystallographic twofold axis. The secondary structure
assignment and overall folding are shown in Figure 2. The
subunit consists of eight antiparallel β strands and five 
α-helical segments. The monomer fold can be described
in terms of two domains. The larger domain 1 is formed by
the β sheets and two of the α helices. This includes the
strand residues 52–58 (S1), 64–75 (S2), 78–84 (S3), 98–103
(S4), 110–120 (S5) and 178–192 (S6) to form a six-stranded
β-barrel structure that is extended by the residues 200–206
(S7) and 211–215 (S8) into an eight-stranded antiparallel β
sheet. One entrance of the barrel structure is flanked by
the N-terminal residues (20–30) and helix H1 (31–44).
Helix H2 (88–95), located between strands S3 and S4, lies
across the other entrance of the β barrel. The smaller
domain 2 packs adjacent to the β-barrel core and helix H2
and is made up of the three remaining α helices, H3
(123–130), H4 (135–143) and H5 (154–166). Thus, the
whole protein subunit consists of a compact eight-stranded
β-sheet core that is surrounded by five α-helical structures. 
There are two major patches of hydrophobic residues in the
central core of the structure. The larger hydrophobic patch,
found exclusively in domain 1, is formed within the
enclosed cavity created by the β-sheet structure, helices H1
and H2, and the N-terminal residues. It involves 40
hydrophobic residues; 11 of them have aromatic sidechains.
The smaller hydrophobic patch is formed by the rim of the
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Figure 1
Schematic diagram illustrating the reaction
catalyzed by PNPOx.
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β sheet (involving strands S3 and S6) of domain 1, the three
helices (H3, H4 and H5) of domain 2 and the isoalloxazine
ring of the FMN molecule. There are 23 hydrophobic
residues that form this patch, nine of which have aromatic
sidechains. The hydrophobic patch residues are highly con-
served among the PNPOx members (Figure 3). 
There are six salt bridges forming secondary structure
contacts, two of them span strands S5 and S6, including
Lys117–Glu186 (2.9 Å) and Glu119–Arg182 (3.3 Å).
Strand S6 is also involved in salt bridges with helix 
H3 (Glu125–Arg182, 2.9 Å) and with strand S7
(Glu189–Arg201, 2.6 Å). The two strands S5 and S6 are
relatively long and these salt bridges might help to main-
tain the structure. The other two remaining salt bridges
are between strands S7 and S8 (Asp200–Arg215, 2.8 Å),
and strand S8 and the turn connecting the strands S7 and
S8 (Glu207–Lys212, 2.5 Å). With the exception of the
Lys117, all the residues involved in the salt bridges are
highly conserved among the PNPOx family. 
Overall structure of the dimer
The structure of the dimer is shown in Figures 4a and b.
There is a total of 54 hydrogen bonds and salt bridges
(< 3.8 Å), and 84 van der Waals contacts (< 4.0 Å) linking
the two monomers. In addition, there are numerous water,
FMN- and phosphate-mediated hydrogen bonds (< 3.8 Å)
linking the monomers. The buried surface area calculated
with the CCP4 program suite (AREAIMOL and DIF-
FAREA) [18] is 5032 Å2 for the dimer. The two FMN
molecules that are bound at the interface also contribute
an additional 628 Å2 to the contact surface area. Each
FMN is located in a deep cavity formed between strands
S1, S2, S3 and helix H2 from domain 1, and helix H4 and
the loop region located between helices H4 and H5 from
domain 2. Completely covering the FMN from the other
side of the cavity are structures from the second monomer,
including strands S4, S5, S6, S7 and S8 (Figures 4a,b)
Three regions along the dimer interface are closely
involved in the monomer–monomer interactions
(Figure 4b). The first involves symmetry-related sec-
ondary structures from both monomers arranged around
the twofold axis (central dimerization interface). These
include strands S1, S4 and the N-terminal residues of
strand S2, which form a narrow channel that extends from
the top to the bottom of the structure. The channel is
elliptical in cross-section, about 40 Å long and varies in
diameter from 6–9 Å. The interface is constituted by the
opposition of sidechains from these strands, similar to 
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Table 1
Data collection and phasing parameters*.
Crystal information
Space group P3121
Unit-cell dimensions (Å) 63.71, 63.71, 125.25
Estimated solvent content (%)† 55
Data collection statistics λ1 λ2 λ3
Wavelength (Å) Edge = 0.97946 Peak = 0.97921 Remote = 0.82944
Resolution (Å) 1.80 (1.86–1.80) 1.80 (1.86–1.80) 1.80 (1.86–1.80)
No. of measurements 250,146 250,195 262,844
No. of unique reflections 26,187 26,196 26,980
I/sigma I 10.0 9.4 7.6
Completeness (%) 93.5 (66.0) 93.6 (66.7) 96.3 (74.2)
Rmerge (%)‡ 7.4 (31.1) 7.8 (30.8) 7.5 (35.7)
MAD phasing statistics λ1 to λ2 λ1 to λ3
Resolution (Å) 2.20 2.20
Rcullis (acentric/centric)§ 0.54/0.53 0.69/0.71
Rcullis–amomalous§ 0.54 0.56
Phasing power (acentric/centric) 2.68/1.68 1.76/1.07
FOM# 0.73
*Numbers in parentheses refer to the outermost resolution shell.
†Solvent content estimated according to Matthews [40].
‡Rmerge = Σ((I) – I)/ΣI. §Rcullis, Rcullis–anomalous, and phasing power are
defined in MLPHARE [30]. #Figure of merit.
Table 2
Structure refinement.
Resolution limit (Å) 55–1.8 (1.91–1.80)
No. of reflections 26,936 (3415)
R factor/Rfree (all data) (%) 21.0 (27.1)/23.3 (27.4)
Rmsd from standard geometry
Bond lengths (Å) 0.010
Bond angles (°) 1.389
Average B-values (Å2)
All non-hydrogen atoms 25.4
Protein atoms 25.0
FMN atoms 14.2
Phosphate atoms 13.5
Water atoms 32.7
Numbers in parentheses refer to the outermost resolution shell.
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N-acetylneuraminate lyase from E. coli [19]. The deeper
layer of the channel is predominantly hydrophobic, and
solvent inaccessible. Ser100 and Gln66 (and their symme-
try-related mates) are the only polar residues located at
the deeper layer of the channel. They form extensive
hydrogen-bond interactions involving their sidechain
atoms and backbone atoms of the residues Val54 O,
Leu101 N and Leu102 N (Figure 4c). The residues found
in the deeper part of the channel have mainly small
sidechains, and almost all of these are conserved or similar
among the PNPOx family. Guarding the top and bottom
entrances of the channel are predominantly hydrophilic
residues and several water molecules. 
The other two dimerization regions, which are identical
and related by the twofold axis, are located at the edges of
the dimer interface (Figure 4b). Each interface is formed
by domain 1 of one monomer (N-terminal residues, strands
S7 and S8, the turn connecting the strands S6 with S7, and
the C-terminal residues), in contact with domain 2 from the
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Figure 2
Topology and protein fold of the E. coli
PNPOx monomer. (a) Schematic topology
diagram showing the arrangement of
secondary structure in the monomer.
Numbering indicates residues where a
secondary structure motif starts or ends. The
secondary structure was assigned with the
program PROCHECK [17]. The figure was
drawn using CSC ChemDraw (Cambridge
Scientific Computing, Inc). (b) Ribbon
diagram of the overall protein fold complexed
with FMN molecule. α Helices are colored
magenta, and β strands are in cyan. The
secondary structures are labeled. The bound
FMN is shown in ball-and-stick representation.
(c) Stereo drawing showing the Cα trace of
E. coli PNPOx, with every twentieth residue
numbered. The orientation is the same as the
ribbon diagram. The figures were drawn using
MOLSCRIPT [37] and RASTER3D [38] and
labeled using SHOWCASE (Silicon
Graphics, Inc).
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second monomer (helices H4 and H5, and the loop that
connects these two helices). The interface is characterized
by both hydrophobic and hydrophilic contacts, and the loop
region that connects helices H4 and H5 accounts for almost
all of the interactions by one of the monomers. These inter-
actions serve to stabilize the loop, and as expected the loop
has a relatively low B-factor (20.9 Å2) compared with the
average for the protein (25.4 Å2). As pointed out later in this
paper, this loop also contributes residues for both FMN
and phosphate binding. The residues involved in the inter-
subunit salt bridges and hydrogen bonds are highly con-
served in the PNPOx family. 
Comparison with yeast PNPOx
The X-ray structure of yeast PNPOx has been determined
to 2.7 Å (RCSB entry IC10), and is the only currently
known structure in this family of enzymes. The two pro-
teins share 64% sequence similarity (139 residues), with
37% (80 residues) strictly conserved (Figure 3). As
expected, the yeast PNPOx structure is also a dimer with
a similar structural fold as the E. coli PNPOx. Structural
differences between the E. coli and yeast PNPOx struc-
tures are located mainly in regions of loops and turns. The
largest difference is found at the turn located between
strands S7 and S8 where the E. coli PNPOx has a three-
residue insertion whereas the yeast PNPOx has a seven-
residue insertion. Overlap of the Cα atoms shows a root
mean squared deviation (rmsd) of 1.0 Å, excluding the
loop and turn regions that have large deviations (46 of the
199 total residues excluded). Some structural differences
are also observed in the helices, especially H3, H4 and
H5, and the strands show a very good fit to each other. In
particular, residues 161–166 from the helix H5 (average
rmsd 2.1 Å) and residues 136–143 from helix H4 (average
rmsd 1.5 Å) show significant structural deviations. These
two regions have high B-factors (49.3 Å2 and 36.1 Å2,
respectively, compared with an average of 25.4 Å2 for the
whole protein) and might explain the large structural dif-
ferences between these pairs of helices. 
Comparison with non-PNP-binding proteins
A database search with the TOP software package [20]
shows that the E. coli PNPOx topology of the five strands
(S1, S2, S3, S4 and S5) and helices H1 and H2 from
domain 1, and the helix H3 from domain 2 are conserved
in the FMN-binding protein from Desulfovibrio vulgaris
(FMN-bp) [21]. Although, these two proteins have very
similar structural topology, they share very little sequence
homology. Only 12 of the amino acids in the sequence are
strictly conserved, and 29 other residues are similar to
each other. Most of the conserved residues are involved
in the two hydrophobic patches observed in the central
core of the E. coli PNPOx structure. The number of
amino acid residues in FMN-bp is 122 versus 218 in the
E. coli PNPOx. In contrast to the E. coli PNPOx, the
FMN-bp is a monomer [21,22]. Superposition of the 
conserved structural topology (excluding loop regions) for
70 equivalent Cα atoms of the FMN-bp and the E. coli
PNPOx gives an rmsd of 1.4 Å. Omitting regions of large
deviations and superimposing 63 Cα atoms results in an
rmsd of 1.1 Å. The FMN-binding pocket is very similar
to that in E. coli PNPOx and the two FMN molecules
superimpose quite well. In the E. coli PNPOx structure,
the loop located between helices H4 and H5 forms addi-
tional contacts with the FMN, but this loop is absent in
FMN-bp. None of the residues making contact with
FMN in the E. coli PNPOx structure is similar to those of
FMN-bp except for Arg88, which is a lysine in FMN-bp. 
There are other significant differences between these two
structures. In FMN-bp, there is a short loop located within
strand S2, resulting in two strands instead of one as found
in the E. coli PNPOx structure. The region represented by
residues 131–177 that connects helix H3 and strand S6 in
E. coli PNPOx (three loops, and helices H4 and H5) is
missing from the FMN-bp. Instead, there is a short loop of
eight residues that connects the conserved helix H3 and
strand S6 in the FMN-bp. In addition, residues 193–218
(including strands S7, S8 and the C-terminal residues),
which follow strand S6 of the E. coli PNPOx structure, are
missing in FMN-bp. Although, the actual function of the
FMN-bp is unknown, it has a low redox potential of
–325 mV [21], which suggests that this protein functions as
a redox protein like other FMN-binding proteins. A previ-
ous study of FMN-bp showed that it is similar in structure
to a domain of chymotrypsin [22], and the authors made
the argument for the evolutionary relationship between
FMN-bp and chymotrypsin. It also seems plausible that
the genes for FMN-bp and PNPOx have both evolved
from a common redox protein ancestral gene.
Neither the amino acid sequence nor the structure of the
E. coli PNPOx show homology to any other known FMN
binding non-oxidase protein. There are also no sequence
and structure similarities with any reported non-PNP
binding oxidase protein that use FAD or FMN as cofactor. 
FMN-binding site
The two monomers create two enclosed cavities (that run
from the top to the bottom of the dimer), which contain two
FMN-bound molecules separated by approximately 19 Å.
The cavity is funnel-like with the entrance facing the isoal-
loxazine moiety wider and open to the surrounding,
whereas that of the phosphate moiety is smaller and closed
by a web of salt bridges and hydrogen bonds. The flexible
loop between helices H3 and H4 (residues 131–134) and
part of helix H4 (residues 135–140) lie close to the isoallox-
azine side of the FMN-binding pocket entrance. Running
almost parallel and located at the back of these mobile
structures are the extended loop connecting helix H5 to
strand S6 (residues 167–177) and a portion of helix H5
(residues 158–165), that are also characterized by high 
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B-factors. None of these mobile residues makes contact
with the FMN molecule. It appears certain that the
entrance close to the isoalloxazine moiety acts as the entry
point for PNP into the pocket because it is much wider than
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ZYMM F P C V R M M L L K G H T K D G F V F F T N L G - S - R K G H E L L E N P V A T L L F H W K K L R R Q V R I E G A A T L 94
SACC R V
 
S S R I L L F K E L D H R G F T I Y S N W G T S - R K A H D I A T N P N A A I V F F W K D L Q R Q V R V E G I T E H 127
RATN K P S A R M L L L K G F G K D G F R F F T N Y E - S - R K G K E L D S N P F A S L V F Y W E P L N R Q V R V E G P V K K 148
HUMN K P S A R M L L L K G F G K D G F R F F T N F E - S - R K G K E L D S N P F A S L V F Y W E P L N R Q V R V E G P V K K 148
CAEN R P S S R M V L L K A Y T P T G F S F Y T N Y T - S - R K G N Q L E E N P N A A M L F Y W P K V N R Q I R V E G V V E K 152
MYXX R P S A R V V L L K D F D A R G F V F Y T N H E - S - R K G R E A R A H P Y A A L C F Y W Q P L N E Q V R V E G R V E R 172
* * * * * * * * * * * * * * * * * *
130 140 150 160 170
ECOL L S T L E V M K Y F H S R P R D S Q I G A W V S - K Q S S R I S A R G I L E S K F L E L K Q K F Q Q - - - G - - - E V P 173
NEIS L A E K L S D E Y F E S R P Y Q S R L G A W A S - A Q S E V I P N K A V L V A K A A A V G L K H P L - - - - - - - H V P 165
DEIN V P E A E S N D Y F H K R P R E S Q L A A H A S T P Q S A P V E N R A A L E A K F A A L H E Q F P E - - - G T - - T I P 169
SCHI L S R E E T E E Y F K T R P R N S R I G A W A S - P Q S E V I A D R E E L E K R V E E Y K K K F G E - - - D E S V P V P 184
MYCT V S T E E I F T Y W S M R P R G A Q L G A W A S - Q Q S R P V G S R A Q L D N Q L A E V T R R F A D Q D Q - - - - - I P 183
MYCL V D P Q V S E D Y W S K R P R G S Q L G A W A S - H Q S R P I A S R T A L L D Q L L E V T V R F A D S E L - - - - - I P 178
SYNS I D P A E S D A Y F Q S R P R G S Q L G A W A S - P Q S R I V G D R Q E L E D N L A R W E K Q Y E N - - - Q - - - S I P 185
SCHC V P R E T S D A Y F K T R A R G S K L G A W A S - R Q S D V I K N R Q E L D E L T A K N T E R F K D A E D - - - - - I P 182
HAEL I P A E Q S D K Y F A T R P Y T S R I G A W A S - E Q S A V I S N Y K S L L A K A A L V A A K H P L - - - - - - - N V P 184
ZYMM I S D E E A D A Y F A T R A R K S Q L G A W A S - E Q S R P L P A R D V F E K R I A D I E A R Y E G - - - K - - - D V P 147
SACC V N R E T S E R Y F K T R P R G S K I G A W A S - R Q S D V I K N R E E L D E L T Q K N T E R F K D A E D - - - - - I P 181
RATN L P E K E A E N Y F H S R P K S S Q I G A V V S - R Q S S V I P D R E Y L R K K N E E L G Q L Y R E Q - - - - - - E V P 201
HUMN L P E E E A E C Y F H S R P K S S Q I G A V V S - H Q S S V I P D R E Y L R K K N E E L E Q L Y Q D Q - - - - - - E V P 201
CAEN L P D E M A V A Y W N S R P V A S R I G S K S S - D Q S K V V P D R E F L E S K K V A L T E L S V R E G A Q - - - A I P 208
MYXX V T D A E A D A Y F Q S R A R G S Q V G A W A S - L Q S Q P L A T R E E L E A R V A E V E Q K Y A G - - - Q - - - P V P 225
* * * * * * * * * * * * * * * * * * *
180 190 200 210 218
ECOL L P S F W G G F R V S L E Q I E F W Q G G E H R L H D R F L Y Q R - - E N D A - - - - - - - - - - - - - - - W K I D R L A P 218
NEIS R P P H W G G Y I V I P D L L E F W Q G R P S R L H D R I Q Y R L - - L D G G - - - - - - - - - - - - - - - W I R E R L S P 210
DEIN R P A F W G G Y R V Q V Q E W E F W Q G R P N R M H D R F R Y A R - - D G D G - - - - - - - - - - - - - - - W R L D R L M P 214
SCHI V P D F W G G I R I V P L E I E F W Q G G K Y R L H D R F S F R R N T L D E - - - - - - - - - - - - - - - D Y E L V R L A P 231
MYCT V P P G W G G Y R I A P E I V E F W Q G R E N R M H N R I R V A N - - G - - - - - - - - - - - - - - - - - - - R L E R L Q P 224
MYCL L P P N W G G Y L I V P E V V E F W Q G R E N R V H N R I R V T G - - G - - - - - - - - - - - - - - - - - - - C I E R L Q P 219
SYNS R P P H W G G F R V I P H R I E F W Q G R P S R L H D R L Q F N L - - L D G Q - - - - - - - - - - - - - W H R Q R L A P 230
SCHC R P P Y W G G L R I V P L E I E F W Q G R P S R L H D R F V Y R R - - K T E N D P - - - - - - - - - - - - - W K V V R L A P 229
HAEL R P D Y W G G Y L V V P E T V E F W Q G R P S R L H D R I R Y R K - - E S D N - - - - - - - - - - - - - - - W I R E R L S P 229
ZYMM R P P Y W T G F R V S P I R M E F W N D R E F R L H E R E L F T L - - N D G R - - - - - - - - - - - - - - - W Q S E F L Y P 192
SACC C P D Y W G G L R I V P L E I E F W Q G R P S R L H D R F V Y R R - - K T E N D P - - - - - - - - - - - - - W K V V R L A P 228
RATN K P E Y W G G Y I L Y P Q V M E F W Q G Q T N R L H D R I V F R R - - G L A T G D S P L G P M T H H G E E D W V Y E R L A P 261
HUMN K P K S W G G Y V L Y P Q V M E F W Q G Q T N R L H D R I V F R R - - G L P T G D S P L G P M T H R G E E D W L Y E R L A P 261
CAEN K P E S W G G Y H L I P R Y F E F W Q G Q S D R L H D R I V F E R - - D V D V - - - - - - - - - - - - - - - W L L K R L S P 253
MYXX R P P H W S G F R V V P D R I E F W H A Q E S R L H D R H V Y L R - - E D G G - - - - - - - - - - - - - - - W R T Q M L Y P 270
Structure
Figure 3
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the other entrance and is in an open configuration. More-
over, the mobile secondary structures at this entrance can
easily rotate to facilitate the entry and exit of the substrate
PNP and the product PLP from the active site. 
The FMN is involved in extensive interactions with the
E. coli PNPOx dimer, and the specific interactions between
the FMN and the protein are shown in Figure 5 and sum-
marized schematically in Figure 6. Trp191 and Val69 are
the only two residues that make hydrophobic contacts of
less than 3.8 Å with the isoalloxazine ring. These two
residues are conserved in the PNPOx family. In addition to
the hydrophobic contacts, the isoalloxazine ring and the
protein are also involved in extensive hydrogen-bond inter-
actions. The two oxygen and three nitrogen atoms (O2, O4,
N1, N3 and N5) make six direct hydrogen bonds and two
water-mediated interactions with the residues Leu70 N(O),
Tyr82 O(N), Thr83 OG1, Gln146 NE2 and Arg197 NH1.
The ribityl hydroxyl moiety forms five hydrogen bonds and
two water-mediated interactions with the protein residues
Gln111 NE2, Ile68 O, Trp191 NE1, Glu189 OE1, Pro218
OT1, Gln146 NE2 and Lys89 NZ. The phosphate moiety
of FMN makes a series of hydrogen bonds and salt bridges
with the amino acid residues Lys89 NZ, Arg67 NE, Arg88
NE(N), Ser147 OG and Arg201 NH2.
The residues that make contact with the FMN molecule
occur in sequence motifs that are highly conserved in the
PNPOx family (Figure 3). These include the motif
RIVLLK (residues 67–72), VFYTN (residues 80–84),
SRKA (residues 87–90), EFWQG (residues 189–193) and
RLHDR (residues 197–201). Gln146 and Ser147 are the
only two residues that are not part of any conserved motifs
that are also strictly conserved in the family. The alignment
of E. coli and yeast PNPOx shows that all five-sequence
motifs and the residues Gln146 and Ser147 involved in
FMN binding adopt similar conformations. A distinguishing
characteristic of the E. coli PNPOx FMN binding domain is
that the guanidinium group of Arg197 points towards the
isoalloxazine ring, whereas it points away from the ring in
the yeast structure. It should be noted that the sidechain of
Arg197 is disordered in the E. coli structure and has a high
B-factor. The present structure also shows Arg133, which is
located at the mouth of the FMN-binding pocket, to be dis-
ordered, and was refined in two alternate positions. One
position is close to that of the yeast PNPOx. 
Phosphate-binding site
A non-covalently bound phosphate is found at the dimer
interface in a shallow crevice formed by the loop region
located between helices H4 and H5 of one monomer, the
N-terminal residues, strands S7 and S8 and the C termi-
nus of the other monomer. Unlike the FMN molecule,
which is almost buried in the protein with only the top of
the isoalloxazine ring open to the solvent, the whole phos-
phate site is easily accessible to the solvent. It is remark-
ably well ordered with a lower average B-factor (13.5 Å2)
than the rest of the protein (25.4 Å2). The oxygens make
hydrogen bonds/salt bridges with residues Arg23
(2.8–3.7 Å), Arg24 (2.9 Å), Arg153 (2.8–3.8 Å) and Arg215
(2.8–3.8 Å). In addition there are water-mediated hydro-
gen bonds with residues Arg23, Arg24, Arg25, Arg153 and
Gly154. Approximately half of the contacting residues in
this area share sequence homology in the PNPOx family.
The binding site is very similar to that of yeast PNPOx,
although no phosphate was observed in the yeast struc-
ture. The E. coli PNPOx protein was purified with 20 mM
phosphate buffer, and crystallized with a precipitant solu-
tion containing 50 mM phosphate. It is quite conceivable
that phosphate was not used during the purification and
crystallization of yeast PNPOx. 
Discussion
The large surface contact area, the number of hydrogen
bonds and salt bridges, and the significant van der Waals
contacts at the dimer interface are consistent with this
enzyme remaining a dimer after removal of FMN to form
apoenzyme. It also explains the complete retention of a
functional protein during the harsh conditions of incuba-
tion used in removing the bound FMN, which requires
about 2 h at low pH in high salt [6].
The structural determination of E. coli PNPOx permits an
evaluation of data from previously published work on this
enzyme. A number of variations in the structure of FMN
were tested for its ability to bind and restore catalytic
activity when added to the rabbit liver apoenzyme [8].
These studies showed that the binding site of the phos-
phate moiety of FMN probably contained arginine
residues and held the phosphate as a dianion. Indeed, we
find that the phosphate site for FMN does contain Arg201,
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Figure 3 continued
Multiple sequence alignment of 15 PNPOx proteins. The numbering
above the alignment corresponds to the E. coli sequence. Proteins
used in the sequence alignment are as follows (database ID numbers
are shown in parentheses): ECOL, E. coli (P28225); NEIS, Neisseria
meningitidis (CAB84799); DEIN, Deinococcus radiodurans
(AAF10072); SCHI, Schizosaccharomyces pombe (CAB60247);
MYCT, Mycobacterium tuberculosis (O06207); MYCL,
Mycobacterium leprae (O33065); SYNS, Synechocystis sp.
(P74211); SCHC, Schizophyllum commune (AAC28862); HAEL,
Haemophilus influenzae (P44909); ZYMM, Zymomonas mobilis
(AAD53919); SACC, Saccharomyces cerevisiae (Baker’s yeast)
(P38075); RATN, Rattus norvegicus (O88794); HUMN, Homo
sapiens (AK001397); CAEN, Caenorhabditis elegans (AAA21167);
MYXX, Myxococcus xanthus (P22259). Residues that are identical in
all the members are colored green. Residues that are identical in at
least ten of the sequences are colored magenta, and those that are
conserved but not identical are in purple. Red asterisks indicate
residues that are directly involved in binding of the FMN. Purple
asterisks indicate residues that form the two patches of the
hydrophobic core in the monomeric structure. Green asterisks show
residues common to FMN binding and the hydrophobic patch.
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Arg88, Arg67, and Lys89 (Figures 5 and 6), as well as the
positive dipole end of helix H2. Further studies with the
rabbit liver PNPOx showed that the binding pocket is very
specific for the ribityl group because either blocking,
removing, or changing the chirality of the hydroxyl groups
abolishes binding [8]. Our structure shows that the ribityl
group is buried deep in the active site with a number of
hydrogen bonds to the hydroxyl groups, so it is not surpris-
ing that the enzyme is very specific for this part of the
FMN molecule. Further studies showed that isoFMN (6,7
dimethyl rather than 7,8 dimethyl) was bound by apo
PNPOx and restored most of its catalytic activity. Our
structure shows that this edge of the isoalloxazine ring of
FMN is not restricted by contacts and moving the 8-
methyl group to the 6 position would be allowed, even
enhancing the hydrophobic contact with Leu70. Fluores-
cence studies suggested a tryptophan residue is located
near the isoalloxazine ring in the rabbit liver enzyme [23].
As shown in Figure 5, Trp191 is a conserved residue in
PNPOx and it is less than 4 Å from the isoalloxazine ring.
The catalytic mechanism for PNP oxidases has not been
determined with certainty. One proposed mechanism
involves a hydride transfer from the substrate (PNP or
PMP) C4′ carbon to N5 of FMN. The removal of a
hydride ion would leave a C4′ carbocation, which would
be stabilized by resonance with O3′ of PNP. A second
proposed mechanism involves removal of a proton from
C4′ of the substrate to form a carbanion, which then
makes a nucleophilic attack on N5 of FMN to form a
covalent adduct, which subsequently breaks down to
form FMNH2 and the oxidized substrate [12,13]. The C4′
carbanion would be stabilized by resonance with a proto-
nated N1 in the pyridine ring resulting in a quinonoid
intermediate as observed in many PLP enzymes. The
carbanion pathway requires a catalytic base near the sub-
strate C4′ carbon and a positive charge near N1–C2 of
FMN to stabilize the anionic charge on N1 that develops
in this mechanism. The conserved Lys89 can function as
the positive charge near N1–C2 of FMN if one assumes
some movement of helix H2 upon substrate binding. A
previous protein modification study of rabbit liver
PNPOx suggested that there is a histidine residue at the
substrate-binding site that acts as the catalytic base [14]. 
Figure 7 shows PNP modeled into the active site of E. coli
PNPOx so that C4′ of PNP is in close proximity of N5 of
FMN. PNP could only be modeled so that it is on the 
re face of N5 of FMN. The best fit allows the phosphate
moiety to be in hydrogen-bonding and electrostatic inter-
action distance with Lys72, Tyr129, Ser137 and Arg133.
Arg133 can exist in two alternate conformations, one where
it overlaps the position of the modeled PNP substrate and
the other making direct interaction with the phosphate
moiety, as shown in Figure 7. Previous studies indicated
that a critical arginine residue was involved in substrate
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Figure 4
Overall dimer structure of the E. coli PNPOx. The two monomers are
colored magenta and cyan, respectively. Two orthogonal views of the
protein molecule in ribbon representation. (a) Bound FMN and
phosphate molecules are shown in ball-and-stick representations.
The FMN is surrounded by the two monomers, whereas the
phosphate is readily accessible to the solvent. (b) The three
dimerization regions (central and edge dimerization interfaces) that
stabilize the dimer. Bound FMN and phosphate molecules are shown
in ball-and-stick representation. (c) The central dimerization interface
channel, showing the only observed hydrogen-bond network
interaction in the deeper layer of the channel. The protein residues
involved in the hydrogen-bond network are shown in ball-and-stick
representation. The figures were drawn using MOLSCRIPT [37] and
RASTER3D [38] and labeled using SHOWCASE.
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binding and our model suggests it is Arg133 [10]. Another
possibility is Arg197, which could also interact with the
phosphate moiety. The Arg197 is characterized by a high
B-factor and broken sidechain electron density, suggesting
considerable flexibility in its sidechain. In the structure
shown in Figure 5, the guanidinium group of Arg197 is
pointing directly to the isoalloxazine ring (3.9 Å), but in
this position it overlaps with the modeled PNP substrate.
The Arg197 conformation can easily be rearranged during
catalysis to either make a hydrogen bond to O3′ or the
phosphate moiety of PNP substrate. In Figure 7 we have
moved the Arg197 sidechain. All five residues (Lys72,
Tyr129, Arg133, Ser137 and Arg197) that make contact
with the modeled PNP are totally conserved in the PNPOx
family, with the exception of Lys72 and Ser137,which are
present in 14 of the 15 sequences. Arg133 and Arg197 can
be tested as the residues previously suggested to be critical
for PNP binding of the phosphate moiety of PNP by
changing them to alanine. These mutants should exhibit a
lower affinity for PNP and also change the chemical shift
of its 31P NMR signal. Only one water molecule (labeled
H2O 429A in Figure 6) lies close to the modeled PNP
(2.4 Å), and makes a hydrogen-bond interaction with the
C4′ hydroxyl of the modeled PNP substrate.
The conserved His199 in our model is not in a position
to abstract a proton from C4′ of PNP, which would
suggest a role in the carbanion intermediate pathway.
Rather His199 forms a hydrogen bond with O3′ of PNP.
Our model would therefore favor the hydride ion trans-
fer mechanism forming a carbocation at C4′, rather than
removal of a proton by His199 to form a carbanion at C4′.
In addition, the carbanion mechanism would be
expected to have an aspartic acid or glutamic acid
residue to stabilize the protonated N1 of PNP as found
in many PLP enzymes, but the E. coli PNPOx structure
shows no aspartic acid or glutamic acid residue closer
than 11 Å to the N1 of PNP. However, the totally con-
served C-terminal carboxylate of Pro218 is 5.3 Å from
N1 in the structure, which cannot be excluded as a puta-
tive counter anion to N1.
For the hydride ion transfer mechanism, the 4′-hydroxyl of
PNP substrate is in a position to hydrogen bond to O4 of
FMN as shown in Figure 7. In this position the pro R
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Figure 6
Schematic diagram showing the hydrogen-bond/salt-bridge
interactions between FMN and the dimeric protein. Residues from the
two respective monomers are denoted with the letters A and B.
Hydrogen bonds and/or salt bridges are shown as dashed lines. The
figure was drawn using CSC ChemDraw.
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Structure
Figure 5
Stereoview of the FMN cofactor and its
environment. Hydrogen-bond and/or salt-
bridge interactions are shown between the
FMN (yellow) and the protein residues from
monomer A (cyan) and monomer B
(magenta). Atoms are shown in stick
representation, with oxygens and nitrogens
colored red and blue, respectively. Water
molecules are shown as red spheres.
Interactions are shown as black dashed lines.
The figure was generated with INSIGHTII
[39] and labeled using SHOWCASE.
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proton on C4′ of PNP would be transferred to the re face of
N5 of FMN. However, a nearly 180° rotation of the C4–C4′
bond of PNP would place the hydroxyl within hydrogen
bonding distance of O3′ of PNP and place the pro S hydro-
gen of PNP above N5 of FMN. Previous studies with
rabbit PNPOx showed that the enzyme lacked stereospeci-
ficity for the proton on C4′ of PNP [12]. Our model could
explain this result if the C4′ hydroxyl can hydrogen bond in
these two different modes. A key experiment to distin-
guish between the hydride ion transfer or carbanion mech-
anisms will be to change His199 to either asparagine or
alanine. If His199 is a base then both of these mutations
will result in a several order of magnitude decrease in cat-
alytic activity, but if it is functioning through its hydrogen
bond to O3′ of PNP then the His199→Asn mutant should
retain more activity in comparison to the His199→Ala
mutant. His106 is also a possible active site residue except
it is on the opposite side of the FMN ring and is not con-
served in other PNPOx enzymes (Figure 7). 
A study with the sheep brain PNPOx showed that the sub-
strate analog bis-PLP, where two PLP molecules are con-
nected through the phosphate moiety, is a good inhibitor
and can be covalently attached by reduction with NaBH4,
suggesting that it forms an aldimine linkage with a lysine
residue [3]. A 13-residue peptide containing the covalently
bound bis-PLP was isolated containing a lysine–lysine
sequence. We can find no sequence in E. coli PNPOx that
is homologous to this peptide. We have observed that PLP
binds tightly to E. coli PNPOx at a non-catalytic site, but
this bound PLP is not reduced with NaBH4 to form a stable
secondary amine, suggesting it is not present as an aldimine
[24]. It is possible that this tight binding PLP site is located
at the phosphate-binding site that is present in the crystal
structure and that this is the site previously found to cova-
lently attach the bis-PLP structure after reduction with
NaBH4 in the sheep brain enzyme. Modeling of PLP into
this site, using the phosphate ion as the anchor, shows that
there is room for PLP and that the protein can make
several hydrogen bonds to the aldehyde and the 3′-pheno-
late oxygen as well as the interaction at the phosphate site.
Site-directed mutants of the arginine residues (Arg23,
Arg24, Arg25 and Arg153) that interact with the phosphate
will aid in determining if this site is the location of the PLP
tight binding site. Currently, we are working on obtaining
E. coli PNPOx crystals with bound PLP. 
Biological implications
Pyridoxal 5′-phosphate (PLP) is required as a cofactor
by more than 50 enzymes involved in amino acid metab-
olism, and for phosphorylase activity in glucose metabo-
lism. There are both de novo biosynthetic and salvage
pathways for generating PLP in vivo. Both of these
pathways require pyridoxine 5′-phosphate oxidase
(PNPOx), making this enzyme activity essential to all
cells. Failure to make adequate supplies of PLP in
mammals is usually manifested first as neurological dis-
orders. PNPOx is the first enzyme in both the biosyn-
thetic and salvage pathways for which a structure has
been determined. PLP is a very reactive molecule
forming complexes with most small nucleophiles and
proteins in the cell, suggesting that the pool of free PLP
is maintained at a very low level. This would require
PNPOx to be highly regulated in vivo so that it produces
PLP only at the rate it is required. Product inhibition
has been suggested as one mechanism for regulation, but
other mechanisms are likely to be discovered and their
elucidation will require structural information.
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Figure 7
Stereoview of the active site of E. coli PNPOx,
showing the expected binding mode of a PNP
substrate (green) at the re face of the FMN
cofactor (yellow). The protein residues are
colored cyan and magenta for monomer A and
monomer B, respectively. Atoms are shown in
stick representation. Nitrogen and oxygen
atoms of FMN and PNP, and sidechain atoms
of the protein are colored blue and red,
respectively. The N1, O3′ and C4′ atoms of
the PNP are labeled. Also labeled are the N1,
N5 and O4 atoms of the FMN. The figure was
generated with INSIGHTII [39] and labeled
with SHOWCASE.
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The oxidase class of enzymes uses molecular oxygen as
substrate, producing hydrogen peroxide as a product.
PNPOx is the smallest member of this class of enzymes.
A hydride ion transfer from pyridoxine 5′-phosphate
(PNP) to N5 of flavin mononucleotide (FMN), or the
generation of a carbanion intermediate of PNP by
removal of a proton, which then attacks N5 of FMN, are
two currently proposed mechanisms for this enzyme. The
current model supports the hydride transfer mechanism.
However, conclusive differentiation between the two pro-
posed mechanisms requires the design of site-directed
mutants of the enzyme for which structural information is
essential.
Materials and methods
Preparation of the SeMet derivative of E. coli PNPOx
Recombinant E. coli PNPOx in a pET22 inducible vector [6] was
expressed in the Met auxotroph E. coli strain B834(DE3) (Novagen).
Cells were grown in M9 medium containing 2 mM MgSO4, 0.4%
glucose, 0.1 mM CaCl2, 25 mg/l FeS04, 40 mg/l of all amino acids
except methionine, 1 g/l thiamine hydrochloride, 100 mg/l ampicillin,
10 µM FMN and 40 mg/l seleno-L-methionine. A 5 l culture was grown
at 37°C until OD660 reached 1.4, then induced with 0.5 mM IPTG and
growth continued at 27°C for 7 h. The cells were harvested and the
enzyme purified as previously described [6]. About 15 mg of pure E. coli
PNPOx was obtained. Purity was judged by SDS-PAGE to be greater
then 98%. Presence of SeMet was confirmed by mass spectrometry.
Crystallization
Crystallization conditions used to crystallize the native E. coli PNPOx
[25] failed to give crystals for the SeMet PNPOx–FMN complex. The
crystals of the SeMet complex were subsequently grown at 22°C in
hanging drops containing 4 mg/ml E. coli SeMet PNPOx–FMN
complex, 0.65–0.9 M ammonium formate, 2.5 mM 2-mercaptoethanol,
50 mM potassium phosphate and 50 mM Hepes/NaOH at pH 7.5. The
reservoir solution contained 1.3–1.8 M ammonium formate, buffered
with 100 mM Hepes/NaOH at pH 7.0. Suitable crystals for X-ray analy-
sis appeared in about four weeks. Although the native and the SeMet
crystals appear to have different crystal shapes, the cell constants and
space groups are isomorphous. The crystals are trigonal with typical
cell dimensions of a = b = 63.71 Å, c = 125.25 Å, space group P3121,
with one monomer in the asymmetric unit. 
X-ray data collection
The multiple wavelength anomalous diffraction (MAD) data were col-
lected at cryogenic temperature (100K) using the Advanced Photon
Source (APS) station 19ID. For the data collection, the crystals were
washed for a few minutes in a cryo-protectant solution containing 28%
(w/v) PEG 8000, 10% (v/v) glycerol and 100 mM Hepes pH 7.0.
Three wavelengths were selected for data collection corresponding to
the maximum f′′ (peak), the minimum f′ (edge), and a reference wave-
length (remote) at 0.82944. The data sets were collected using inverse
beam geometry. A total of (180 × 3)° of data were measured using a 1°
oscillation angle measured for 5 s. The intensity data were processed
and scaled with DENZO/SCALEPACK [26] using the HKL2000
package. Details of the data collection statistics are given in Table 1.
Phasing, model building and structure refinement 
The unmerged data for the peak wavelength output from the
SCALEPACK were processed with the program SORTAV [27] to
remove outlying observations. The Shake-and-Bake direct methods
procedure, as implemented in the computer program SnB [28], was
used to determine the heavy-atom positions. This data set for the peak
wavelength was scaled and processed with the DREAR program
package [29] to derive the renormalized E values corresponding to the
anomalous differences. A total of 1000 trials of SnB were executed
using the 200 largest E values and 1500 triple phase invariants. Five
random positions were used to calculate phases at the beginning of
each trial after which the random phases were subjected to 20 cycles
of phase refinement. At the end of each trial, the five largest peaks
were subjected to three additional cycles of phase refinement. Analysis
of the minimum function values from the 1000 trials showed a bimodal
distribution indicating two trials had converged to solutions. The heavy-
atom parameters were refined using isomorphous and anomalous dif-
ferences, with the maximum-likelihood method incorporated in
MLPHARE program [30] of the CCP4 package. This yielded experi-
mental phases to 2.00 Å and an overall figure of merit of 0.67. The
phases were further improved by solvent flattening and the resolution
was extended to 1.85 Å using DM [31]. The resultant map showed
several secondary structure features and was readily interpretable. 
The initial model was built using the ARP/wARP program [32,33]. Ini-
tially, the program was used to build a pseudo-protein model consisting
of non-connected atoms into the DM solvent-flattened map. This model
was then used to refine against the data set at the remote wavelength
to 1.8 Å resolution. The resulting improved map was then used to auto-
matically trace the polypeptide chain. Repeated cycles of restrained
refinement with the program REFMAC [34] incorporated in the
ARP/wARP protocol resulted in 181 peptides being traced in three
chains consisting of 11, 73 and 91 amino-acid residues. The program
was able to automatically fit about 78% of the 181 mainchain peptides
with sidechains. 
Combining the partial structure phases with the MAD phases allowed
manual tracing of the remaining parts of the chain with the exception of
the 19 N-terminal residues, which are missing from the final structure.
The 199 residue continuous polypeptide chain was subsequently
refined against the 1.8 Å data set at the remote wavelength using the
program CNS [35] with all measured reflections. Both overall
anisotropic B-factor corrections and bulk solvent corrections were
applied. Rigid body refinement, and subsequent conjugate gradient
minimization and simulated annealing, resulted in an R factor of 33.9%
and Rfree of 36.2% (for 5% of the data). Clear densities were identified
for FMN and phosphate molecules. These were included in the model,
and subsequent simulated annealing and individual B-factor refinement
resulted in R factor of 25.6% and Rfree of 28.4%. Repeated cycles of
rebuilding in TOM [36] and addition of 128 water molecules lowered
the R factor to a final value of 21.0% and Rfree of 23.3%. Five
sidechains were refined in two alternate conformations, including two
SeMet residues (113 and 127), Cys43, His91 and Arg133. 
All model building and manual adjustments were performed with the
program TOM. The stereochemistry of the model was constantly evalu-
ated with PROCHECK. 
Accession numbers
The atomic coordinate set has been deposited in the Protein Data
Bank with accession code 1DNL.
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